Some small molecular inhibitors targeting specific E3 ligases, such as Nutlin and MI-319, have shown high binding potency and selectivity for Mdm2 in the treatment of HCC and other cancers40,41. The gene discussed is MDM2; the disease is hepatocellular carcinoma.